CryoLife (United States)
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CryoLife (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
34%
Total
Publications
148
Total Open
Publications
50
Total
Citations
3.4K
Open Access
Percentage
34%
Total
Publications
148
Total Open
Publications
50
Total
Citations
3.4K
Breakdown
Publisher Open
23%
Both
9%
Other Platform Open
2%
Closed
66%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
13
Hybrid 27%
13
No Guarantees 45%
21
Other Platform Open
Domain 72%
13
Other Internet 22%
4
Institution 11%
2
Preprint 11%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 13 |
DOI | Other Internet | 4 |
University of Milano-Bicocca - BOA | Institution | 1 |
OSF Preprints - Arabixiv | Preprint | 1 |
Imperial College London - Spiral | Institution | 1 |
DASH - Digital Access to Scholarship at Harvard | Institution | 1 |
arXiv | Preprint | 1 |